Literature DB >> 20621159

APP(DeltaNL695) expression in murine tissue downregulates CNBP expression.

Dana M Niedowicz1, Tina L Beckett, Chris J Holler, Adam M Weidner, M Paul Murphy.   

Abstract

The cellular nucleic acid binding protein (CNBP) is a ubiquitously expressed protein involved in regulation of transcription and translation. CNBP, and its encoding gene ZNF9, have been shown to be involved in type 2 myotonic dystrophy. Both Alzheimer's disease (AD) and sporadic inclusion body myositis (sIBM) are age-related degenerative diseases associated with the accumulation of beta-amyloid. Overexpression of amyloid precursor protein (APP) in mice has been used to generate models of both diseases. We show here that overexpression of APP in skeletal muscle from a mouse model of sIBM reduces the expression of CNBP significantly. We examined CNBP expression in a brain-specific APP-overexpressing strain, and a whole body APP knock-in strain, and found that there was a reduction in CNBP expression in tissue expressing APP(Swe). We conclude that expression of APP(Swe) in murine tissue induces a decrease in CNBP expression. This effect does not appear to be due to alterations in CNBP transcription. APP(Swe) expression may provide a tool for the study of CNBP regulation and clues to the roles of both proteins in disease. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621159      PMCID: PMC2921452          DOI: 10.1016/j.neulet.2010.07.006

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  41 in total

1.  Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.

Authors:  R Siman; A G Reaume; M J Savage; S Trusko; Y G Lin; R W Scott; D G Flood
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

2.  Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.

Authors:  C L Liquori; K Ricker; M L Moseley; J F Jacobsen; W Kress; S L Naylor; J W Day; L P Ranum
Journal:  Science       Date:  2001-08-03       Impact factor: 47.728

3.  The zinc-finger protein CNBP is required for forebrain formation in the mouse.

Authors:  Wei Chen; Yuqiong Liang; Wenjie Deng; Ken Shimizu; Amir M Ashique; En Li; Yi-Ping Li
Journal:  Development       Date:  2003-04       Impact factor: 6.868

4.  Effects of nonsteroidal anti-inflammatory drugs on amyloid-beta pathology in mouse skeletal muscle.

Authors:  Tina L Beckett; Dana M Niedowicz; Christa M Studzinski; Adam M Weidner; Robin L Webb; Christopher J Holler; Rachel R Ahmed; Harry LeVine; M Paul Murphy
Journal:  Neurobiol Dis       Date:  2010-05-20       Impact factor: 5.996

5.  cDNA cloning and developmental expression of cellular nucleic acid-binding protein (CNBP) gene in Xenopus laevis.

Authors:  A De Dominicis; F Lotti; P Pierandrei-Amaldi; B Cardinali
Journal:  Gene       Date:  2000-01-04       Impact factor: 3.688

6.  Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.

Authors:  Michael C Sugarman; Tritia R Yamasaki; Salvatore Oddo; Julio C Echegoyen; M Paul Murphy; Todd E Golde; Mehrdad Jannatipour; Malcolm A Leissring; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

Review 7.  Myotonic dystrophy type 2.

Authors:  J Finsterer
Journal:  Eur J Neurol       Date:  2002-09       Impact factor: 6.089

8.  Zebrafish cnbp intron1 plays a fundamental role in controlling spatiotemporal gene expression during embryonic development.

Authors:  Andrea M J Weiner; Miguel L Allende; Nora B Calcaterra
Journal:  J Cell Biochem       Date:  2009-12-15       Impact factor: 4.429

9.  AbetaPP/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis.

Authors:  Feng Xu; Mary Lou Previti; Marvin T Nieman; Judianne Davis; Alvin H Schmaier; William E Van Nostrand
Journal:  J Neurosci       Date:  2009-04-29       Impact factor: 6.167

10.  APP binds DR6 to trigger axon pruning and neuron death via distinct caspases.

Authors:  Anatoly Nikolaev; Todd McLaughlin; Dennis D M O'Leary; Marc Tessier-Lavigne
Journal:  Nature       Date:  2009-02-19       Impact factor: 49.962

View more
  6 in total

1.  Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology.

Authors:  Christopher J Holler; Paulina R Davis; Tina L Beckett; Thomas L Platt; Robin L Webb; Elizabeth Head; M Paul Murphy
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  CNBP acts as a key transcriptional regulator of sustained expression of interleukin-6.

Authors:  Eunhye Lee; Taeyun A Lee; Ji Hyun Kim; Areum Park; Eun A Ra; Sujin Kang; Hyun Jin Choi; Junhee L Choi; Hyunbin D Huh; Ji Eun Lee; Sungwook Lee; Boyoun Park
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

3.  CNBP controls IL-12 gene transcription and Th1 immunity.

Authors:  Yongzhi Chen; Shruti Sharma; Patricia A Assis; Zhaozhao Jiang; Roland Elling; Andrew J Olive; Saiyu Hang; Jennifer Bernier; Jun R Huh; Christopher M Sassetti; David M Knipe; Ricardo T Gazzinelli; Katherine A Fitzgerald
Journal:  J Exp Med       Date:  2018-11-15       Impact factor: 14.307

4.  Cellular nucleic acid-binding protein is essential for type I interferon-mediated immunity to RNA virus infection.

Authors:  Yongzhi Chen; Xuqiu Lei; Zhaozhao Jiang; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-29       Impact factor: 11.205

5.  Beyond the binding site: in vivo identification of tbx2, smarca5 and wnt5b as molecular targets of CNBP during embryonic development.

Authors:  Pablo Armas; Ezequiel Margarit; Valeria S Mouguelar; Miguel L Allende; Nora B Calcaterra
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

6.  Yeast Gis2 and its human ortholog CNBP are novel components of stress-induced RNP granules.

Authors:  Marta Rojas; George W Farr; Cesar F Fernandez; Laura Lauden; John C McCormack; Sandra L Wolin
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.